Study S001656

The Anabolic Effects of GLP-1 Agonism to Prevent Lean Muscle Losses During Very-low Calorie Diets (VLCDs) for Weight Loss

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT05606471
Acronym: SemVLCD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 45
Start: 2021-09-15
Primary completion: 2023-07-28
Lead sponsor: University of Nottingham
Conditions: Type 2 Diabetes Mellitus in Obese
Interventions: DRUG:Semaglutide Pen Injector [Ozempic]; DIETARY_SUPPLEMENT:Very-low Calorie Diet
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Muscle protein synthesis rate [6 weeks]
Muscle protein breakdown rate [6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.